The manifestations of amiodarone pulmonary toxicity (APT) are generally nonspecific, and a diagnosis requires appropriate clinical history, laboratory testing consistent with toxicity, and exclusion of other disease entities. To our knowledge, hemoptysis associated with APT has not been described before; the following report describes such a case. We suggest that APT should be considered among the differential diagnosis of hemoptysis in a patient receiving amiodarone.